Overview
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/02/05 | Phase 2 | UNKNOWN | Haihe Biopharma Co., Ltd. | ||
2019/11/05 | Phase 1 | Withdrawn | |||
2019/08/01 | Phase 1 | Suspended | |||
2019/06/20 | Phase 1 | Terminated | |||
2017/08/24 | Phase 1 | UNKNOWN | Haihe Biopharma Co., Ltd. | ||
2017/04/17 | Phase 1 | Completed | Haihe Biopharma Co., Ltd. | ||
2016/04/22 | Phase 2 | Withdrawn | Teresa Helsten, MD | ||
2014/07/29 | Phase 2 | Terminated | |||
2014/04/09 | Phase 2 | Terminated | |||
2014/02/04 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.